1259789

Glaxo Wellcome S.A. — FEI 3004195227

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aranda De Duero (Spain)

Additional Details

Mutual Recognition Agreement (MRA)